News
BWAY
11.12
+4.22%
0.45
BrainsWay Investor Deck Details Q3 2026 Growth and Scale
TipRanks · 23h ago
Brainsway reports Q3 EPS 5c, consensus 9c
TipRanks · 1d ago
BrainsWay Q3 2026 Earnings Call Transcript
Benzinga · 1d ago
BrainsWay GAAP EPS of $0.05 misses by $0.04, revenue of $18.15M beats by $0.35M
Seeking Alpha · 1d ago
BrainsWay Reports 34% Third-Quarter Revenue Growth to $18.1 Million
TipRanks · 1d ago
Here are the major earnings before the open Tuesday
Seeking Alpha · 1d ago
Weekly Report: what happened at BWAY last week (1102-1106)?
Weekly Report · 2d ago
Brainsway announces strategic collaboration with Mindful Health Solutions
TipRanks · 11/02 12:40
BrainsWay Partners With Mindful Health Solutions To Pursue Strategic Initiatives To Expand Patient Access To Health Treatments
Benzinga · 11/02 12:33
Weekly Report: what happened at BWAY last week (1026-1030)?
Weekly Report · 11/02 09:28
BrainsWay Ltd. Amends Notice of Annual General Meeting Scheduled for November 25, 2026
NASDAQ · 10/26 20:32
BrainsWay Expands U.S. Insurance Coverage for Deep TMS Treatment of OCD to Over 118 Million Lives
NASDAQ · 10/26 13:43
BrainsWay Lifts Deep TMS OCD Insurance Coverage to Over 118 Million Americans
TipRanks · 10/26 11:57
Weekly Report: what happened at BWAY last week (1019-1023)?
Weekly Report · 10/26 09:28
BrainsWay Sets November 25, 2026 Annual Shareholder Meeting With Auditor, Board and Equity Votes
TipRanks · 10/21 21:25
Analysts Offer Insights on Healthcare Companies: Brainsway (BWAY), Cullinan Management (CGEM) and BeOne Medicines (ONC)
TipRanks · 10/20 10:00
BrainsWay Strikes Strategic Deep TMS Partnership With Southern California’s Inland Psychiatric Medical Group
TipRanks · 10/19 16:24
Brainsway: Buy Rating Reaffirmed on Strategic Momentum and Reimbursement Expansion; 12‑Month Price Target Maintained at $19
TipRanks · 10/19 16:06
Brainsway Price Target Maintained With a $19.00/Share by HC Wainwright & Co.
Dow Jones · 10/19 14:38
HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $19 Price Target
Benzinga · 10/19 14:28
More
Webull provides a variety of real-time BWAY stock news. You can receive the latest news about Brainsway Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About BWAY
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.